From the *Department of Cardiothoracic Critical Care Medicine and ECMO Unit, Glenfield Hospital, University Hospitals of Leicester National Health Service Trust, Leicester, UK
†Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
‡University of Toronto, Interdepartmental Division of Critical Care Medicine, Toronto, Ontario, Canada
§Sorbonne Université, GRC 30, RESPIRE, UMRS_1166-ICAN, Institute of Cardiometabolism and Nutrition 75651, Paris Cedex 13, France
¶Service de Médecine Intensive-Réanimation, Institut de Cardiologie, Assistance Publique–Hôpitaux de Paris (APHP), Sorbonne Université Hôpital Pitié–Salpêtrière, Paris, France.
Submitted for consideration July 2022; accepted for publication in revised form September 2022.
Disclosures: T.C. is supported by the NIHR. V.Z. is the chair and H.Y. co-chair of the Protecting the Right Ventricle Network (PRORVnet), with E.F. and M.S. as members. E.F. reports personal fees from ALung Technologies, Aerogen, Baxter, GE Healthcare, Inspira, and Vasomune outside the submitted work. M.S. reports lecture fees from Getinge, Drager, and Xenios outside the submitted work. The other author has no conflicts of interest to report.
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML and PDF versions of this article on the journal’s Web site (www.asaiojournal.com).
Correspondence: Thomas Chad, Department of Cardiovascular Sciences, University of Leicester, University Hospitals of Leicester National Health Service Trust, Leicester, UK. Email: [email protected]; Twitter: @thechadologist.
